Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Aug;67(2):e81-3.
doi: 10.1016/j.jaad.2011.10.028.

Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases

Jack L Arbiser, Maria Bips, Anne Seidler, Michael Y Bonner, Charles Kovach
Case Reports

Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases

Jack L Arbiser et al. J Am Acad Dermatol. 2012 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cutaneous Melanoma Metastases. Clinical appearance of the patient at presentation a), immediately after treatment b) and four months after treatment c). Arrows mark the original tumor site a,b) and at follow-up c).
Figure 2
Figure 2
Cutaneous Melanoma Metastases. Histology of a representative tumor removed during palliative debulking. 2a) represents a low powered view and 2b) represents a high powered view. Note the numerous mitoses in 2b).
See this image and copyright information in PMC

References

    1. Perry BN, Govindarajan B, Bhandarkar SS, Knaus UG, Valo M, Sturk C, et al. Pharmacologic Blockade of Angiopoietin-2 Is Efficacious against Model Hemangiomas in Mice. J Invest Dermatol. 2006 Oct;126(10):2316–22. - PubMed
    1. Woodmansee CS, McCall MW. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatol Surg. 2009 Aug;35(8):1286–9. - PubMed
    1. Fisher GH, Lang PG. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Arch Dermatol. 2003 Jul;139(7):945–7. - PubMed
    1. Turza K, Dengel LT, Harris RC, Patterson JW, White K, Grosh WW, et al. Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis. J Cutan Pathol. 2010 Jan;37(1):94–8. - PMC - PubMed

MeSH terms